Key Details
Price
$1.86Annual ROE
-23.02%Beta
-0.78Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
N/ARecent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Screeners with GELS included
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, announced today that it has expanded its operations in the United States with the appointment of Adam Bendell as President of U.S. Operations.
NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announced today the closing of its initial public offering of 1,300,000 ordinary shares at a public offering price of US$4.00 per share. The ordinary shares commenced trading on the Nasdaq Global Market on October 29, 2024 under the symbol “GELS.”
FAQ
- What is the primary business of Gelteq Limited Ordinary Shares?
- What is the ticker symbol for Gelteq Limited Ordinary Shares?
- Does Gelteq Limited Ordinary Shares pay dividends?
- What sector is Gelteq Limited Ordinary Shares in?
- What industry is Gelteq Limited Ordinary Shares in?
- What country is Gelteq Limited Ordinary Shares based in?
- Is Gelteq Limited Ordinary Shares in the S&P 500?
- Is Gelteq Limited Ordinary Shares in the NASDAQ 100?
- Is Gelteq Limited Ordinary Shares in the Dow Jones?
- When does Gelteq Limited Ordinary Shares report earnings?